Logo image of MDWT

MIDWEST HOLDING INC (MDWT) Stock Fundamental Analysis

NASDAQ:MDWT - Nasdaq - US59833J2069 - Common Stock - Currency: USD

26.99  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MDWT. MDWT was compared to 144 industry peers in the Insurance industry. MDWT may be in some trouble as it scores bad on both profitability and health. MDWT is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MDWT has reported negative net income.
In the past year MDWT had a positive cash flow from operations.
In the past 5 years MDWT reported 4 times negative net income.
In the past 5 years MDWT reported 4 times negative operating cash flow.
MDWT Yearly Net Income VS EBIT VS OCF VS FCFMDWT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of MDWT (-0.10%) is worse than 72.22% of its industry peers.
MDWT has a worse Return On Equity (-17.23%) than 81.94% of its industry peers.
With a Return On Invested Capital value of 0.23%, MDWT perfoms like the industry average, outperforming 42.36% of the companies in the same industry.
Industry RankSector Rank
ROA -0.1%
ROE -17.23%
ROIC 0.23%
ROA(3y)-0.9%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDWT Yearly ROA, ROE, ROICMDWT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 100 -100

1.3 Margins

MDWT has a Operating Margin (7.60%) which is in line with its industry peers.
MDWT does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 7.6%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDWT Yearly Profit, Operating, Gross MarginsMDWT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

MDWT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MDWT remains at a similar level compared to 1 year ago.
Compared to 1 year ago, MDWT has a worse debt to assets ratio.
MDWT Yearly Shares OutstandingMDWT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M
MDWT Yearly Total Debt VS Total AssetsMDWT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of MDWT is 0.25, which is an excellent value as it means it would take MDWT, only 0.25 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MDWT (0.25) is better than 95.14% of its industry peers.
A Debt/Equity ratio of 1.82 is on the high side and indicates that MDWT has dependencies on debt financing.
MDWT's Debt to Equity ratio of 1.82 is on the low side compared to the rest of the industry. MDWT is outperformed by 90.28% of its industry peers.
Even though the debt/equity ratio score it not favorable for MDWT, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 0.25
Altman-Z N/A
ROIC/WACC0.03
WACC7.98%
MDWT Yearly LT Debt VS Equity VS FCFMDWT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MDWT Yearly Current Assets VS Current LiabilitesMDWT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2M 4M 6M 8M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.32% over the past year.
Looking at the last year, MDWT shows a very strong growth in Revenue. The Revenue has grown by 378.45%.
Measured over the past years, MDWT shows a very strong growth in Revenue. The Revenue has been growing by 67.60% on average per year.
EPS 1Y (TTM)57.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)378.45%
Revenue growth 3Y274.72%
Revenue growth 5Y67.6%
Sales Q2Q%1733.93%

3.2 Future

Based on estimates for the next years, MDWT will show a very strong growth in Earnings Per Share. The EPS will grow by 208.68% on average per year.
MDWT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.73% yearly.
EPS Next Y828.57%
EPS Next 2Y208.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year73.04%
Revenue Next 2Y34.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDWT Yearly Revenue VS EstimatesMDWT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MDWT Yearly EPS VS EstimatesMDWT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDWT. In the last year negative earnings were reported.
MDWT is valuated reasonably with a Price/Forward Earnings ratio of 8.54.
MDWT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MDWT is cheaper than 67.36% of the companies in the same industry.
MDWT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.49.
Industry RankSector Rank
PE N/A
Fwd PE 8.54
MDWT Price Earnings VS Forward Price EarningsMDWT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MDWT is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.01
EV/EBITDA N/A
MDWT Per share dataMDWT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

MDWT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MDWT's earnings are expected to grow with 208.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y208.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDWT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MIDWEST HOLDING INC

NASDAQ:MDWT (12/20/2023, 8:23:45 PM)

26.99

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)03-25 2024-03-25/amc
Inst Owners1%
Inst Owner Change0%
Ins Owners8033.91%
Ins Owner Change0%
Market Cap100.94M
Analysts45.71
Price Target27.54 (2.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1485.07%
Min EPS beat(2)-430.5%
Max EPS beat(2)3400.65%
EPS beat(4)2
Avg EPS beat(4)671.12%
Min EPS beat(4)-430.5%
Max EPS beat(4)3400.65%
EPS beat(8)4
Avg EPS beat(8)362.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)95.87%
Min Revenue beat(2)62.12%
Max Revenue beat(2)129.61%
Revenue beat(4)3
Avg Revenue beat(4)44.19%
Min Revenue beat(4)-56.58%
Max Revenue beat(4)129.61%
Revenue beat(8)4
Avg Revenue beat(8)-9.97%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-12.41%
EPS NY rev (3m)-12.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)99900%
Revenue NY rev (1m)13.87%
Revenue NY rev (3m)13.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.54
P/S 1.13
P/FCF 1.01
P/OCF 1.01
P/B 7.37
P/tB 7.37
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)3.16
Fwd EY11.72%
FCF(TTM)26.64
FCFY98.7%
OCF(TTM)26.74
OCFY99.07%
SpS23.92
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -17.23%
ROCE 0.29%
ROIC 0.23%
ROICexc 0.25%
ROICexgc 0.26%
OM 7.6%
PM (TTM) N/A
GM N/A
FCFM 111.36%
ROA(3y)-0.9%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF 0.25
Debt/EBITDA N/A
Cap/Depr -1.51%
Cap/Sales 0.41%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.98%
ROIC/WACC0.03
Cap/Depr(3y)4.44%
Cap/Depr(5y)20.66%
Cap/Sales(3y)3.18%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y828.57%
EPS Next 2Y208.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)378.45%
Revenue growth 3Y274.72%
Revenue growth 5Y67.6%
Sales Q2Q%1733.93%
Revenue Next Year73.04%
Revenue Next 2Y34.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y216.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y462.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y464.3%
OCF growth 3YN/A
OCF growth 5YN/A